Basis: FMP quote price / unrounded FMP forward EPS in the trading currency, available after its recorded retrieval time. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is N/A as of 2026-10-06T19:16:31.186Z.
Consensus retrieved: 2026-10-06T11:02:08.843Z. This records retrieval, including cache reads, rather than vendor publication. The calculation uses the separately dated price and estimate available at its as-of time.
Calculation as of: 2026-10-06T19:16:31.186Z.
Quote observation: 2026-10-06T19:13:34.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 4f3bc52aaee10dc4864d073eee8720ed85d0d11e7a3d16422bde167dd05b99a5
Forward PE Ratio (N/A) = Dated Quote Price ($10.14) / Consensus Forward EPS ($-1.38)
FORWARD PE RATIO
N/A
electroCore, Inc.
Market Cap
$91.47M
Forward PE Ratio
N/A
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| electroCore, Inc. (ECOR) | $91.47M | N/A |
| Rallybio Corporation (RLYB)vs › | $89.74M | N/A |
| ImmuCell Corporation (ICCC)vs › | $89.56M | N/A |
| CareCloud, Inc. (CCLD)vs › | $89.45M | 7.65 |
| Biomea Fusion, Inc. (BMEA)vs › | $90.74M | N/A |
| Neumora Therapeutics, Inc. Common Stock (NMRA)vs › | $88.86M | N/A |
| Equillium, Inc. (EQ)vs › | $91.07M | N/A |
| PMV Pharmaceuticals, Inc. (PMVP)vs › | $88.53M | N/A |
| Conexeu Sciences Inc. (CNXU)vs › | $91.78M | N/A |
| Park Dental Partners, Inc. Common Stock (PARK)vs › | $93.48M | 12.47 |
Trailing P/E
N/A
reported TTM EPS
Forward P/E
N/A
consensus EPS · fiscal year ending 2026-12-31
At the dated quote price of $10.14, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $-1.38 | $-1.45 – $-1.32 | 4 | n/m |
| 2027-12-31 | $-0.62 | $-0.74 – $-0.49 | 3 | n/m |
| 2028-12-31 | $0.18 | $-0.43 – $0.51 | 3 | 56.4x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
